Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Toll-like receptor 4-activated neuroprotective microglia subpopulation survives via granulocyte macrophage colony-stimulating factor and JAK2/STAT5 signaling.
Both endoplasmic reticulum and mitochondrial pathways are involved in oligodendrocyte apoptosis induced by capsular hemorrhage.
Pharmacological Alternatives for the Treatment of Neurodegenerative Disorders: Wasp and Bee Venoms and Their Components as New Neuroactive Tools.
Granzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo.
Natalizumab Use In Multiple Sclerosis: A Real World Evidence (Rwe) Analysis of Its Impact on Nhs Resources In England.
An unusual presentation of X-linked adrenoleukodystrophy.
Comment on the Paper by Esen et al. Entitled ´Evaluation of Choroidal Vascular Changes in Patients with Multiple Sclerosis Using Enhanced Depth Imaging Optical Coherence Tomography´.
Thy28 protects against anti-CD3-mediated thymic cell death in vivo.
Fecundity in women with multiple sclerosis: an observational mono-centric study.
Concurrence of multiple sclerosis and brain tumors.
Optic neuritis with positive HLA-B27: Characteristic phenotype in the Chinese population.
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.
Annotation of functional variation within non-MHC MS susceptibility loci through bioinformatics analysis.
Neural correlates of episodic future thinking impairment in multiple sclerosis patients.
An aza-anthrapyrazole negatively regulates Th1 activity and suppresses experimental autoimmune encephalomyelitis.
Applying the RE-AIM Framework to Inform the Development of a Multiple Sclerosis Falls-Prevention Intervention.
Work Participation and Executive Abilities in Patients with Relapsing-Remitting Multiple Sclerosis.
Chemokine biomarkers in central nervous system tissue and cerebrospinal fluid in the Theiler's virus model mirror those in multiple sclerosis.
Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction.
A Preliminary Comparative Assessment of the Role of CD8+ T Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.
[The role and place of high-dose immunosuppressive therapy and autologous transplantation of hematopoietic stem cells for autoimmune diseases].
A leading role for NADPH oxidase in an in-vitro study of experimental autoimmune encephalomyelitis.
New evidence for teriflunomide in multiple sclerosis.
Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation.
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis].
Pages
« first
‹ previous
…
649
650
651
652
653
654
655
656
657
…
next ›
last »